NeueHealth, Inc. (NYSE:NEUE – Get Free Report) CFO Jay Matushak sold 1,860 shares of the company’s stock in a transaction on Friday, March 7th. The shares were sold at an average price of $7.19, for a total value of $13,373.40. Following the completion of the transaction, the chief financial officer now directly owns 22,227 shares in the company, valued at approximately $159,812.13. This trade represents a 7.72 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Jay Matushak also recently made the following trade(s):
- On Monday, January 6th, Jay Matushak sold 4,970 shares of NeueHealth stock. The shares were sold at an average price of $7.33, for a total value of $36,430.10.
NeueHealth Trading Up 0.3 %
NEUE opened at $6.92 on Wednesday. The stock’s 50-day moving average price is $7.33 and its 200 day moving average price is $5.99. NeueHealth, Inc. has a 12-month low of $3.79 and a 12-month high of $8.32. The firm has a market cap of $57.33 million, a price-to-earnings ratio of -0.14 and a beta of 0.56.
Analyst Upgrades and Downgrades
Check Out Our Latest Stock Analysis on NeueHealth
Hedge Funds Weigh In On NeueHealth
Hedge funds have recently bought and sold shares of the company. Partners Group Holding AG acquired a new position in NeueHealth during the 3rd quarter worth about $463,000. Northern Trust Corp lifted its stake in NeueHealth by 66.8% during the 4th quarter. Northern Trust Corp now owns 32,644 shares of the company’s stock worth $242,000 after acquiring an additional 13,074 shares in the last quarter. Finally, Virtu Financial LLC acquired a new stake in NeueHealth in the 4th quarter valued at about $76,000. Institutional investors and hedge funds own 63.88% of the company’s stock.
About NeueHealth
NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.
Further Reading
- Five stocks we like better than NeueHealth
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- Why Are These Companies Considered Blue Chips?
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- Best Aerospace Stocks Investing
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.